PSJ Web Site
J-STAGE
  Software Requirements
Microsoft Internet Explorer 5.01 or higher and Netscape Navigator 4.75 or higher are recommended.


J.Health Sci., 51(3), 362-364, 2005

Protective Effect of (-)-Epigallocatechin Gallate on Acute Experimental Colitis

Miyako Mochizuki* and Noboru Hasegawa

Department of Nutrition and Food Science, Gifu Women's University, 80 Taromaru, Gifu 501-2592, Japan

We studied the ameliorative effect of (-)-epigallocatechin gallate (EGCG) on inflammatory bowel disease (IBD) induced by ethanolic 2,4,6-trinitrobenzene sulfonic acid (TNBS) in male 7-week-old rats. Intestinal lesions were associated with macroscopic damage score and measured as increase in myeloperoxidase (MPO) activity in mucosa. Pretreatment with EGCG (30 mg/kg daily i.g. for 10 days) significantly reduced macroscopic damage score, inhibited MPO activity and enhanced superoxide dismutase activity. These observations confirmed that EGCG can ameliorate acute experimental colitis by suppression of superoxide generation from colonic tissue.